Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by sunny3999on Jun 04, 2018 2:26pm
157 Views
Post# 28121422

RE:RE:CGC 40, APH 12??????????????????

RE:RE:CGC 40, APH 12??????????????????
MaskMatrix wrote:
True, same as WEED to APH, same thing. Don't know what the hell is wrong with APH. I hope someone could get a real insight as what's has been going on, and what to expect in future.
Please those who really have something to say make a comment.


TSX killed Aphria's performance with the ridiculous US issue through fingerpointing from other CEO's. As Marketing with Snoop Dog years earlier is not an issue for TSX and even Constellation investment is fine for TSX its how you judge.

Big Money wants to see Canopy as winner in the game.

Aphria had to restructure their game plan and lost lots of effort and time.

So they had to a re-route for global approach and tried to keep pace by buying expensive Nuuvera and suffering dilution since. 

Canopy suffered 6 Month buying Mettrum and lost more than 50% of its all time high from 17.89 to 7,80 CAD.  

Aphria will perform but still waiting for the the right moment - earnings will look much better than any other LP,  right now the Peers are all hyped - there will be a late awakening. 

Aphria is the most undervalued stock i have seen in this Cannabis space.  

Intrinsic Value is at least 50 CAD latest by end of 2019 -  wait for a partner announcement from Liqueur, Tabac, Pharma Industry and the SP will follow.... 
Bullboard Posts